All posts by Dan Thibeault

Health Value Assessments -008



Welcome to Prostate Cancer & You, a series of podcasts produced by the Massachusetts Prostate Cancer Coalition. Today’s podcast features a discussion on health value assessments, drug costs, and the potential implications for men diagnosed with prostate cancer. Interviewed on this topic are Robert Popovian, Doctor in  Pharmacy and Vice President, US Government Relations at Pfizer Inc, and William Smith, PhD, Visiting Fellow on Life Sciences at the Pioneer Institute of Boston.


MPCC Symposium -007



Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition.

Today’s podcast features interviews with several attendees and presenters at the 2019 Massachusetts Prostate Cancer Coalition Symposium on May 10. First up is Mark Anthony Hunter of The Goddard School and a member of the MPCC board. Mark’s father had prostate cancer and he discusses the impact it had on his Dad, as well as the entire family.

The Goddard School is sponsoring its Second annual Benefit Golf Tournament for Men’s Health on Monday, June 17 at the Ferncroft Country Club. Proceeds will benefit MPCC as well as The Senator Edward W. Brooke Scholarship. To register go to www.ferncroftcc.com/goddardschool.

Jacques Carter, MD, Beth Israel Deaconess Medical Center, talks about current issues with PSA testing after The United States Preventive Services Task Force (USPSTF) updated its recommendations, which was the topic of his presentation at the Symposium.

Mark Kennedy of the Boston Public Health Commission, discusses a new initiative, PRECISE (precision, care intervention, screening, and empowerment). It is a consensus concept program that is a smarter look at new concepts in PSA testing. Mark co-presented on this topic with Dr. Carter at the Symposium.

Jamie Bearse is president & CEO of Zero, The End of Prostate Cancer. He discusses his organization’s mission to advance research, focusing on the Department of Defense (DOD) funding and research, and encourage action from volunteers and supporters via the Run/Walk series, and the Zero 360 patient navigator program. The 2019 Zero Prostate Cancer Run/Walk-Boston  is on Sunday, September 9 and starts at Newton City Hall.

Prostate Cancer Support Group leaders Bill Tinney and Gary Halvorsen discuss the important role that support groups and peer-to-peer conversations have on the newly diagnosed, those just starting or involved in ongoing treatment. Go here for a list of support groups in the Commonwealth.


Quoc-Dien Trinh, MD -006



Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Quoc-Dien Trinh, MD, assistant professor of surgery at Harvard Medical School  and co-director of the Dana-Farber/Brigham and Women’s Prostate Cancer Center.  On this podcast he discusses the gap in prostate cancer survival of African American men compared to Caucasian men. His data shows that the biological differences in tumor aggressiveness among African American men may have been exaggerated, and the gap in survival is more likely to be the result of racial inequity and lack of access to quality care.

At the May 10 Prostate Cancer Symposium his session is “Racial Variations in Prostate Cancer Care: Differences or disparities.” Go here for more information and to register.


Glenn Bubley, MD -005



Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Glenn Bubley, MD, director of the Division of Genitourinary Medical Oncology at the Beth Israel Medical Center  and associate professor of medicine at Harvard Medical School. He is the 2009 recipient of the Jack Colbert Memorial Award.

On this podcast he discusses the good news about new treatments for metastatic and non-metastatic prostate cancer. Important clinical trials have been performed that have shown that earlier treatment of metastatic disease with combinations of existing agents have provided a major improvement in overall and cancer specific survival. This includes combinations of hormonal agents like Lupron with Abiraterone or Lupron with the chemotherapeutic agent Docetaxel.

At the May 10 Prostate Cancer Symposium his session is “Newer Therapeutic Strategies for Advanced Prostate Cancer.” Go here for more information and to register.


Adam Kibel, MD -004



Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview Adam Kibel, MD, chief, Division of Urology at Brigham and Women’s Hospital and the Elliott Carr Cutler professor of surgery in urology, Harvard Medical School. On this podcast he discusses the many changes and advances that have been made in the treatment of prostate cancer in the last several years. He is a member of the MPCC Medical Advisory Committee. At the May 10 Prostate Cancer Symposium he will be a panelist on “Treating the Prostate with Radiation or Surgery in Men with a Small Number of Bone Metastases” with Drs. Paul Nguyen and Matthew Robinson, MD Go here for more information and to register.


Aria Olumi, MD -003



Welcome to Prostate Cancer & You, a series of podcasts sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with Aria Olumi, MD, chief of Urologic Surgery at Beth Israel Deaconess Medical Center, the endowed Janet & William DeWolf Professor of Surgery at Harvard Medical School, and he serves as the Chair of Research for the American Urological Association. He will be discussing the Changing Landscape of Prostate Cancer Screening.  If you are interested in hearing more about this topic from Dr. Olumi, he will be presenting at the 2019 Massachusetts Prostate Cancer Symposium on Friday, May 10 at the Newton Marriott. Go here for more information and to register.

 


Richard Lee & Mark Hedstrom -002



Today’s podcast features interviews with Mark Hedstrom, global director, program commercialization, for Movember, an organization dedicated to funding research and building awareness on prostate cancer and men’s health, and  MPCC Medical Advisory Committee member Richard Lee, MD, PhD,  medical oncologist at Massachusetts General Hospital and a cutting-edge researcher. As his patients have said, “ Dr. Lee’s humanity is as large as his scientific expertise.”

 


Jason Efstathiou, Lynn Basilio and Garth Greimann -001



Welcome to the first in a series of podcasts entitled Prostate Cancer & You, sponsored by the Massachusetts Prostate Cancer Coalition. Today’s podcast features an interview with MPCC board members Jason Efstathiou, MD, DPhil, professor at Harvard Medical School and director, Genitourinary Service, Department of Radiation Oncology massgeneral.org, and clinical co-director, The Claire and John Bertucci Center for Genitourinary Cancers Multidisciplinary Clinic massgeneral.org at Massachusetts General Hospital, Lynn Basilio, senior director, Primary Care Systems at the American Cancer Society cancer.org; and Garth Greimann, senior advisor with Berkshire Partners and secretary-treasurer of MPCC. They will be discussing advances in prostate cancer diagnosis and treatment and providing information on the resources available through MPCC.